BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12442660)

  • 41. Neurocomputational models of motor and cognitive deficits in Parkinson's disease.
    Wiecki TV; Frank MJ
    Prog Brain Res; 2010; 183():275-97. PubMed ID: 20696325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A new twist on the anatomy of dystonia: the basal ganglia and the cerebellum?
    Jinnah HA; Hess EJ
    Neurology; 2006 Nov; 67(10):1740-1. PubMed ID: 17130402
    [No Abstract]   [Full Text] [Related]  

  • 43. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
    Liu B; Dluzen DE
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efficacy of bilateral subthalamic nucleus (STN) stimulation in Parkinson's disease.
    Erola T; Heikkinen ER; Haapaniemi T; Tuominen J; Juolasmaa A; Myllylä VV
    Acta Neurochir (Wien); 2006 Apr; 148(4):389-94. PubMed ID: 16284705
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Myeloperoxidase in the neurodegenerative process of Parkinson's disease].
    Teismann P
    Dtsch Med Wochenschr; 2014 Jan; 139(3):99-102. PubMed ID: 24277448
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Patterns of neuronal activity in the basal ganglia nucleus in parkinsonian patients with levodopa-induced dyskinesia].
    Li XY; Zhuang P; Li YJ
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(23):1607-12. PubMed ID: 19035099
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Striatal dysfunction increases basal ganglia output during motor cortex activation in parkinsonian rats.
    Belluscio MA; Riquelme LA; Murer MG
    Eur J Neurosci; 2007 May; 25(9):2791-804. PubMed ID: 17561844
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Magnetic resonance imaging-based volumetric analysis of basal ganglia nuclei and substantia nigra in patients with Parkinson's disease.
    Geng DY; Li YX; Zee CS
    Neurosurgery; 2006 Feb; 58(2):256-62; discussion 256-62. PubMed ID: 16462479
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Parkinson's disease tremor: pathophysiology.
    Hallett M
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S85-6. PubMed ID: 22166464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Function of cortical basal nuclei: Pathophysiology of Parkinson's disease].
    Takakusaki K
    Nihon Seirigaku Zasshi; 2003; 65(4-5):113-29. PubMed ID: 12884733
    [No Abstract]   [Full Text] [Related]  

  • 51. Plasticity of the nigropallidal pathway in Parkinson's disease.
    Whone AL; Moore RY; Piccini PP; Brooks DJ
    Ann Neurol; 2003 Feb; 53(2):206-13. PubMed ID: 12557287
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A neural network model of Parkinson's disease bradykinesia.
    Cutsuridis V; Perantonis S
    Neural Netw; 2006 May; 19(4):354-74. PubMed ID: 16359844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Basal ganglia: functional perspectives and behavioral domains.
    Saint-Cyr JA
    Adv Neurol; 2005; 96():1-16. PubMed ID: 16383208
    [No Abstract]   [Full Text] [Related]  

  • 54. Ultrastructural chemoanatomy of the basal ganglia: an overview.
    Pasik P; Pasik T; Holstein GR
    Adv Neurol; 1987; 45():59-66. PubMed ID: 2881451
    [No Abstract]   [Full Text] [Related]  

  • 55. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits.
    Levy R; Dubois B
    Cereb Cortex; 2006 Jul; 16(7):916-28. PubMed ID: 16207933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The current model of basal ganglia organization under scrutiny.
    Parent A; Cicchetti F
    Mov Disord; 1998 Mar; 13(2):199-202. PubMed ID: 9539330
    [No Abstract]   [Full Text] [Related]  

  • 57. [Implications of the strio-nigro-striated ring in extrapyramidal function].
    Poirier LJ
    Mars Med; 1971; 108(3):177-82. PubMed ID: 4995915
    [No Abstract]   [Full Text] [Related]  

  • 58. Modeling basal ganglia for understanding Parkinsonian reaching movements.
    Magdoom KN; Subramanian D; Chakravarthy VS; Ravindran B; Amari S; Meenakshisundaram N
    Neural Comput; 2011 Feb; 23(2):477-516. PubMed ID: 21105828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stn-dbs activates the target area in Parkinson disease.
    Montgomery EB; Hilker R
    Neurology; 2009 Jul; 73(4):327; author reply 327-8. PubMed ID: 19636056
    [No Abstract]   [Full Text] [Related]  

  • 60. [Will the mystery of Parkinson's disease be resolved?].
    Lyytinen J; Kaakkola S
    Duodecim; 2005; 121(3):275-84. PubMed ID: 15787285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.